References
- Ashkar S, Weber GF, Panoutsakopoulou V. Etal (osteopontin): an early component of type-l (cell-mediated) immunity. Science 2000, 287, 860-864 https://doi.org/10.1126/science.287.5454.860
- Baron JL, Madri JA, Ruddle NH, Hashim G, Janeway CA Jr. Surface expression of a4 integrin by CD4 T cells is required for their entry into brain parenchyma. J Exp Med 1993, 177, 57-68 https://doi.org/10.1084/jem.177.1.57
- Bayless KJ, Davis GE. Identification of dual alpha 4 beta I integrin binding sites within a 38 amino acid domain in the N-terminal thrombin fragment of human osteopontin. J Biol Chem 2001, 276, 13483-13489 https://doi.org/10.1074/jbc.M011392200
- Bayless KJ, Meininger GA, Scholtz JM, Davis GE. Osteopontin is a ligand for the a4bl integrin. J Cell Sci 1998, 111, 1165-1174
- Brosnan CF, Cannella B, Battistini L, Raine CS. Cytokine localization in multiple sclerosis lesions: correlation with adhesion molecule expression and reactive nitrogen species. Neurology 1995, 45, 16-21 https://doi.org/10.1212/WNL.45.6_Suppl_6.S16
- Cannella B, Raine CS. The adhesion molecule and cytokine profile of multiple sclerosis lesions. Ann Neurol 1995, 37, 424-435 https://doi.org/10.1002/ana.410370404
- Chabas D, Baranzini SE, Mitchell D. The influence of the proinflammatory cytokine,osteopontin, on autoimmune demyelinating disease. Science 2001, 294, 1731-1735 https://doi.org/10.1126/science.1062960
- Chellaiah MA, Hruska KA. The integrin alpha (v) beta (3) and CD44 regulate the actions of osteopontin on osteoclast motility. Calcif Tissue 2003, 72, 197-205 https://doi.org/10.1007/s00223-002-1025-6
- Damle NK, Aruffo A. Vascular cell adhesion molecule I induces T-cell antigen receptor-dependent activation of CD4q T lymphocytes. Proc Natl Acad Sci 1991, 88, 6403-6407
- Elices MJ, Osborn L, Takada Y, Crouse C, Luhowskyj S, Hemler ME, Lobb RR. VCAM-I on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/ fibronectin binding site. Cell 1990, 60, 577-584 https://doi.org/10.1016/0092-8674(90)90661-W
- Lee SJ, Benveniste EN. Adhesion molecule expression and regulation on cell of central nervous system. J Neuroimmunol 1999, 98, 77-88 https://doi.org/10.1016/S0165-5728(99)00084-3
- Leppert D, Lindberg RL, Kappos L, Leib SL. Matrix metalloproteinases: multifunctional effectors of inflammation in multiple sclerosis and bacterial meningitis. Brain Res Rev 2001, 36, 249-257 https://doi.org/10.1016/S0165-0173(01)00101-1
- Liaw L, Almeida M, Hart CE, Schwartz SM, Giachelli CM. Osteopontin promotes vascular cell adhesion and spreading and is chemotactic for smooth muscle cells in vitro. Circ Res 1994, 74, 214-224 https://doi.org/10.1161/01.RES.74.2.214
- Liaw L, Skinner MP, Raines EW, Ross R, Cheresh DA, Schwartz SM, Giachell CM. The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins. J Clin Invest 1995, 95, 713-724 https://doi.org/10.1172/JCI117718
- Matsumoto Y, Ohmori K, Fujiwara M. Microglial and astroglial reaction to inflammatory lesions of experimental autoimmune encephlomyelitis in the rat central nervous system. J Neuroimmunol 1992, 37, 23-33 https://doi.org/10.1016/0165-5728(92)90152-B
-
Melanie Laschinger, Britta Engelhardt. Interaction of
${\alpha}4-integrin$ with VCAM-I is involved in adhesion of encephalitogenic T cell blasts to brain endothelium but not in their transendothelial migration in vitro. J Neuroimmunol 2000, 102, 32-43 https://doi.org/10.1016/S0165-5728(99)00156-3 - Merrill JE, Benveniste EN. Cytokines in inflammatory brain lesions: helpful and harmful. Trends Neurosci 1996, 19, 331-338 https://doi.org/10.1016/0166-2236(96)10047-3
- Miller DH, Khan OA, Sheremata WA, Blumhardt LD, Rice PA, Libonati MA, Willmer-Hulme AJ, Dalton CM, Miszkiel KA, O'Connor PW. A controlled trial of natalizumab for relapsing multiple sclerosis. New Engl J Med 2003, 348, 15-23 https://doi.org/10.1056/NEJMoa020696
- Nemir M, DeVouge MW, Mukherjee BB. Normal rat kidney cells secrete both phosphorylated and nonphosphorylated forms of osteopontin showing different physiological properties. J Biol Chem 1998, 264, 18202-18208
- O'Connor KC, Bar-Or A, Hafler DA. The neuroimmunology of multiple sclerosis: possible roles of T and B lymphocytes in immunopathogenesis. J Clin Immunol 2001, 21, 81-92 https://doi.org/10.1023/A:1011064007686
- Oldberg A, Franzen A, Heinegard D. Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp sequence. Proc Natl Acad Sci USA 1986, 83, 8819-8823
- Raine CS. The Norton Lecture: a review of the oligodendrocyte in the multiple sclerosis lesion. J Neuroimmunol 1997, 77, 135-152 https://doi.org/10.1016/S0165-5728(97)00073-8
- Raine CS, Traugott U. Experimental autoimmune demyelination. Chronic relapsing models and their therapeutic implications for multiple sclerosis. Ann N Y Acad Sci 1984, 436, 33-51 https://doi.org/10.1111/j.1749-6632.1984.tb14774.x
- Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994, 76, 301-314 https://doi.org/10.1016/0092-8674(94)90337-9
- Steffen BJ, Butcher EC, Engelhardt B. Evidence for involvement of ICAM-l and VCAM-l in lymphocyte interaction with endothelium in experimental autoimmune encephalomyelitis in the central nervous system in the SJL/J mouse. Am J Pathol 1994, 145(1), 189-201
- Yednock TA, Cannon C, Fritz LC, Sanchez-Madrid F, Steinman L, Karin N. Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin. Nature 1992, 356, 63-66 https://doi.org/10.1038/356063a0